Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Monte Rosa Therapeutics
One Broadway, 14th floor
Cambridge, MA 02142
Phone: 917-363-0113
https://www.monterosatx.com/

Monte Rosa Therapeutics is a biotechnology company developing small molecules to degrade disease-related proteins. The company has developed a platform to rationally design small molecules that reprogram ubiquitin ligases to eliminate disease drivers previously deemed undruggable. Monte Rosa was launched from founding investor Versant Ventures' Ridgeline Discovery Engine based in the Basel Technology Park.

Key Contact
Name
Markus Warmuth
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
05/26/20 $32,500,000 Series A New Enterprise Associates
Versant Ventures
undisclosed
03/12/21 $95,000,000 Series C Aisling Capital
Amzak Capital Management
Avoro Capital Advisors
BlackRock
Cambridge Capital
Fidelity Management & Research Company
GV
HBM Healthcare Investments
New Enterprise Associates
RTW Investments
T. Rowe Price Associates
Versant Ventures
undisclosed


Featured Reading